Literature DB >> 16713460

Infantile perineal protrusion.

Amor Khachemoune1, Kjetil Kristoffer Guldbakke, Eric Ehrsam.   

Abstract

Infantile perineal protrusion, a relatively newly recognized condition, is underreported in both the dermatologic and pediatric literature. The name "infantile perineal protrusion" has evolved based on the typical anatomic location, morphologic features, and prevalence in prepubertal children. It occurs in 3 settings: constitutional (sometimes genetic or familial); functional (after constipation, diarrhea, or other irritant exposure); or associated with lichen sclerosus et atrophicus. Recognition of infantile perineal protrusion by dermatologists and pediatricians has many implications regarding proper diagnosis and management. The condition may be mistaken for condyloma acuminata or as a sign of trauma, leading to an erroneous investigation of sexual abuse. In this article, we report two new cases and make a thorough review of the literature to elucidate the mechanisms, diagnosis, classification, and management to clarify this often misdiagnosed condition.

Entities:  

Mesh:

Year:  2006        PMID: 16713460     DOI: 10.1016/j.jaad.2006.02.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Infantile perianal pyramidal protrusion: a report of 8 new cases and a review of the literature.

Authors:  N Zavras; E Christianakis; S Tsamoudaki; K Velaoras
Journal:  Case Rep Dermatol       Date:  2012-09-20

2.  Infantile perianal (perineal) pyramidal protrusion.

Authors:  Şule Güngör; Sinan Güngör
Journal:  Indian Dermatol Online J       Date:  2014-12

3.  Anogenital Papular Lesions in Children Five Year Old and Younger: Gender Differences.

Authors:  Hiathem Abu-Alhaija; Elham Zayed; Bayan Abu-Alhaija
Journal:  Med Arch       Date:  2020-02

Review 4.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.